Clinical Study of QSOX1 as a Biomarker for Colon Cancer
NCT ID: NCT05827471
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
400 participants
OBSERVATIONAL
2023-07-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683
Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer
NCT05468177
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
NCT05501353
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
NCT02510118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tumor group
First diagnosis of colon cancer.
Diagnosis of colon cancer
Clinical diagnosis results
Control group
Healthy people.
Diagnosis of colon cancer
Clinical diagnosis results
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnosis of colon cancer
Clinical diagnosis results
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No local or systemic treatment was performed before operation.
* Complete clinical data.
Exclusion Criteria
* Other tumors other than colon cancer.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qianfoshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YunqiuWang
Dr
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QianfoshanHwyq20230305
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.